84-1047-06 Neprilysin-Like Protease, alpha (NEPL-a) 100ul N2030-30

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • The amyloid beta peptide (Ab) of 39-43aa is constitutively produced in brain upon proteolysis of the b-amyloid precursor protein (APP) and exists as fragments of 40, 42 and 43aa (Ab40, Ab42, Ab43).
  • In young and healthy humans, Ab is rapidly catabolized before it can be deposited in the brain.
  • Upon aging or the onset of familial Alzheimer's Disease however, alterations in either synthesis or degradation/ clearance of Ab may contribute to amyloid depositions in the brain.
  • Ab is susceptible to a number of in vivo and in vitro proteases like cathepsin-D and M-13 metalloproteases.
  • The M-13 family comprises several zinc-dependent metalloproteases like DINE, PHEX, KELL, ECE, XCE, neprilysin (NEP) and neprilysin-like proteases (NEPLs).
  • The NEPLs (NEPL-alpha, NEPL-beta, NEPL-gamma) arise from the alternative splicing of a single NEPL gene and are zinc dependent metalloproteases with ~54 % homology to NEP.
  • NEPL-a is a type II trans-membrane metallopeptidase (~100kD non-glycosylated and 120kD glycosylated) containing a highly glycosylated polypeptide chain of 742aa with a HEXXH zinc-binding consensus, cytoplasmic tail and a large extracellular catalytic domain.
  • NPL-a lacks a 23aa sequence present in N-terminal of NEPL-b.
  • In contrast to NEP and NEPL-b which exist in membrane-bound as well as soluble forms, NEPL-a is expressed as membrane-bound form only.
  • In comparison to NEP, the NEPL-a has lower affinity and/or smaller Vmax for Ab and cannot proteolyze cell secreted Ab40 or Ab42 in vivo.
  • Unlike NEP, NEPL-a is not a major in vivo peptidase for degrading endogenous Ab however, it might degrade Ab in Alzheimer patients where Ab is accumulated in excess and an Ab-degradative pathway, alternative to NEP, exists
  • Applications:Suitable for use in ELISA and Western Blot Other applications not tested.
  • Recommended Dilutions:ELISA: 1:5000-1:50,000 using 50-100ng of control peptide (N2030-34) per well
  • Western Blot: 1:1000-1:5000 using ECL.
  • Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:mouse
  • Grade:Serum
  • Purity:Serum
  • Form:Supplied as a liquid, neat serum, 40% glycerol.
  • Specificity:Recognizes mouse Neprilysin-Like Protease, alpha (NEPL-a).
  • Isotype:IgG
  • Calc Applications Abbrev:E
  • Calc Crossreactivity:Mo
  • Immunogen:Synthetic peptide corresponding to 17aa from mouse Neprilysin-Like Protease, alpha (NEPL-a) conjugated to KLH (NO038811.1). Epitope: ~N-terminal, Cytoplasmic domain
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1047-06
型番
N2030-30
入り数
1個
標準価格
181,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る